Skip to main content
Clinical Trials/NCT04361916
NCT04361916TerminatedNot Applicable

Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino)

Mario Negri Institute for Pharmacological Research1 site in 1 country37 target enrollmentStarted: April 21, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
37
Locations
1
Primary Endpoint
SpO2 at hospital entry

Study Overview

Brief Summary

Starting an early home management and monitoring of patients with suspected or confirmed COVID-19 to ensure a rapid and adequate transfer to hospital care.

Assess the feasibility of home monitoring in a pilot study to possibly extend it to a larger scale.

Detailed Description

The study will include adult patients with suspected or confirmed COVID-19 for whom home care is considered appropriate.

Trained health workers will conduct home care monitoring of pulmonary performance using oximetry, Quick Walk Test and Single Breath Count.

Monitoring will be done daily until disappearance of symptoms or hospitalization which will be requested by health workers or study coordination board on the basis of the monitoring results (blood oxygen level SpO2< 90% OR SpO2> 90% with desaturation index of at least 5% at Quick Walk Test)

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • adult patients with suspected or confirmed COVID-19 for whom home care is considered appropriate.

Exclusion Criteria

  • physical, mental or temporary impairments that preclude the conduction of the test

Outcomes

Primary Outcomes

SpO2 at hospital entry

Time Frame: 24 hours

Peripheral blood saturation measured on arrival to the hospital

Secondary Outcomes

  • in-hospital mortality(30 days)
  • need of intubation(30 days)
  • Percentage of hospitalized patients among those with recommendation of hospitalization(30 days)

Investigators

Sponsor
Mario Negri Institute for Pharmacological Research
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Home Care for Patients With COVID-19:... | Clinical Trial